Project IMPACT Immunizations (IMProving America's Communities Together) Scaled Demonstration
NCT03372967 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6234
Last updated 2019-12-13
Summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Conditions
Interventions
- BIOLOGICAL
-
Vaccine administration by a pharmacist
Administration, number and types, of vaccines by a pharmacist
- BEHAVIORAL
-
Unmet vaccination needs identified and met
Identification of unmet vaccination needs and having those needs met
- BEHAVIORAL
-
Vaccination forecast review and patient education
Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs
Sponsors & Collaborators
-
American Pharmacists Association Foundation
lead OTHER
Principal Investigators
-
Benjamin M Bluml, BPharm · American Pharmacists Association Foundation
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-12-12
- Primary Completion
- 2019-11-20
- Completion
- 2019-11-20
Countries
- United States
Study Locations
More Related Trials
-
Age and Response to Flu Vaccines
NCT03328325 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
NCT03722589 ·Status: COMPLETED ·Phase: PHASE4
-
Retail COVID-19 Study
NCT06761612 ·Status: COMPLETED
-
Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A
NCT03315104 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Flu Vaccination and Burden of Illness Among Community-dwelling Elderly With Influenza Like Illness in Brazil
NCT01171157 ·Status: TERMINATED
-
Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects
NCT01651104 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
NCT03331991 ·Status: COMPLETED
-
Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate
NCT00363077 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
NCT01032395 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
NCT00333398 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
NCT03686514 ·Status: TERMINATED ·Phase: PHASE4
-
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
NCT01701752 ·Status: COMPLETED ·Phase: PHASE1
-
Proteomic Profiling for Influenza
NCT00133588 ·Status: COMPLETED ·Phase: PHASE4
-
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
NCT03321968 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age
NCT00397215 ·Status: COMPLETED ·Phase: PHASE2
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity of Influenza Vaccine in Long Term Care
NCT02933723 ·Status: UNKNOWN ·Phase: NA
-
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
NCT03301051 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
NCT00354016 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults
NCT03314662 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults
NCT00386698 ·Status: COMPLETED ·Phase: PHASE2